H
Hao Xie
Researcher at Mayo Clinic
Publications - 61
Citations - 910
Hao Xie is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 15, co-authored 52 publications receiving 609 citations. Previous affiliations of Hao Xie include Cleveland Clinic Lerner College of Medicine & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer.
TL;DR: It is demonstrated that double negativity for expression of YAP1 and CDX2 defines a subgroup of CAC with early onset and aggressive clinical features.
Journal ArticleDOI
Novel methylated DNA markers in plasma detect distant recurrence of colorectal cancer.
Hao Xie,Douglas W. Mahoney,Patrick H. Foote,Kelli N. Burger,Karen A. Doering,William R. Taylor,Xiaoming Cao,Maria McGlinch,Calise K. Berger,Joleen M. Hubbard,Hatim T. Allawi,Graham P. Lidgard,David A. Ahlquist,John B. Kisiel +13 more
TL;DR: This data indicates that methylated DNA markers are broadly informative for early detection of colorectal cancer (CRC) but have not been extensively studied for post-treatment surveillance and diseas...
Journal ArticleDOI
Lymphovascular invasion and nodal metastasis in intramucosal adenocarcinoma of the esophagus and esophagogastric junction.
TL;DR: The tumor parameters predictive of lymphovascular invasion (LVI) and nodal metastases in intramucosal adenocarcinoma (IMAC) of the esophagus and esophagogastric junction are evaluated.
Journal ArticleDOI
Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis
TL;DR: In CAC, histomorphology appeared to be independent of PSC, and PSC is associated with a trend toward shorter OS and PFS in CAC patients with stage I–III diseases.
Journal ArticleDOI
Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long‐term survival in limited stage small‐cell lung cancer
Vinicius Ernani,Lin Du,Helen Ross,Joanne Yi,Jason A. Wampfler,Steven E. Schild,Hao Xie,Karen L. Swanson,Henry D. Tazelaar,Ping Yang +9 more
TL;DR: Investigation of factors and pattern of long‐term survival in patients with limited‐stage small cell lung cancer who achieved a complete response (CR) after chemoradiotherapy found that a subset of SCLC achieves long-term survival.